Related Experiment Video
Updated: Feb 4, 2026

Design of a Biocompatible Drug-Eluting Tracheal Stent in Mice with Laryngotracheal Stenosis
Published on: January 21, 2020
Stenting for intracranial stenosis: potential future for the prevention of disabling or fatal stroke
1Department of Neurology, University of California, Irvine, California, USA.
Insights
Intracranial stenting for stroke prevention showed higher risks initially. However, reduced periprocedural complications in newer trials suggest a potential benefit for preventing disabling strokes.
Area of Science:
- Neurology
- Vascular Neurology
- Interventional Neurology
Background:
- Intracranial stenosis is a significant cause of ischemic strokes, particularly in Asian, African, and Hispanic populations.
- Previous studies like SAMMPRIS indicated higher risks with stenting compared to medical management due to periprocedural complications.
Purpose of the Study:
- To re-evaluate the role of intracranial stenting in preventing disabling or fatal strokes.
- To assess if recent advancements in reducing periprocedural complications alter the risk-benefit profile of stenting.
Main Methods:
- Review of randomized controlled trials and post-market surveillance studies on intracranial stenting for symptomatic severe intracranial stenosis.
- Comparison of periprocedural complication rates and long-term stroke outcomes between stenting and aggressive medical management.
Main Results:
- The SAMMPRIS trial showed higher rates of stroke or death within 30 days for stenting (14.7%) versus medical management (5.8%).
- Periprocedural complications in the stenting group of SAMMPRIS were a major contributor to early adverse events (7.1% vs 1.8%).
- More recent trials (Chinese Angioplasty and Stenting for Symptomatic Intracranial Severe Stenosis, WEAVE) reported significantly lower periprocedural complication rates (2%-2.7%).
Conclusions:
- While early studies suggested medical management superiority due to high periprocedural risks, newer data indicate potential benefits of stenting.
- Reducing periprocedural complications is key to realizing the potential benefit of intracranial stenting for preventing long-term disabling or fatal strokes.
Abstract:
Intracranial stenosis is a common cause of ischaemic strokes, in particular, in the Asian, African and Hispanic populations. The randomised multicentre study Stenting and Aggressive Medical Management for the Prevention of Recurrent stroke in Intracranial Stenosis (SAMMPRIS) showed 14.7% risk of stroke or death in the stenting group versus 5.8% in the medical group at 30 days, and 23% in the stenting group versus 15% in the medical group at a median follow-up of 32.4 months. The results demonstrated superiority of medical management over stenting and have almost put the intracranial stenting to rest in recent years. Of note, 16 patients (7.1%) in the stenting group had disabling or fatal stroke within 30 days mostly due to periprocedural complications as compared with 4 patients (1.8%) in the medical group. In contrast, 5 patients (2.2%) in the stenting group and 14 patients (6.2%) in the medical group had a disabling or fatal stroke beyond 30 days, indicating significant benefit of stenting if periprocedural complications can be reduced. Recently, the results of the Chinese Angioplasty and Stenting for Symptomatic Intracranial Severe Stenosis trial and the Wingspan Stent System Post Market Surveillance Study (WEAVE trial) showed 2%-2.7% periprocedural complications. It is time to evaluate the role of intracranial stenting for the prevention of disabling or fatal stroke.
More Related Videos
Related Concept Videos
Intellectual Disability
Learning Disabilities
Dyslexia
Dyslexia is a...
Mitral Stenosis I: Introduction
Cancer Prevention
Some...
Prevention of Further Absorption of Poison
Preventive Healthcare Services

